Campaigning is set to conclude tomorrow for the first phase of polling in Jharkhand, where 43 assembly constituencies will ...

This was over 28 days in a phase 1 trial. The level of weight loss and the tolerability of the treatment at 100-milligram ...

Neurogene has a $903M market cap with two phase 1/2 assets, NGN-401 for Rett Syndrome and NGN-101 for CLN5 Batten Disease.

More than two years after a gunman shot and killed 19 students and two teachers, the new Legacy Elementary School marks a new ...

Doha believes that Hamas and Israel have not demonstrated a "sincere willingness" to negotiate terms amid the ongoing war.

“Mice treated with 12.5 mg/kg-1 fexagratinib hardly showed any symptoms in the chronic phase of EAE.” Similarly, the therapy ...

Bechtel, the engineering, procurement and construction (EPC) contractor behind the first three planned liquefaction trains at ...

Q3 2024 Earnings Call Nov 08, 2024, 8:30 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants. Prepar ...

J&J’s filing is based on results from the phase 3 AQUILA trial. Among 390 patients with high-risk smoldering multiple myeloma ...

Dynavax Technologies (NASDAQ: DVAX) Q3 2024 Earnings Call Nov 07, 2024, 4:30 p.m. ET ...

MIAMI, Nov. 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and nine months ended September 30, 2024. Highlights from the ...

As Akesobio handled all of the phase 1 and phase 2 clinical trials, Summit didn't need to pay research and development (R&D) ...